Clinical Trial Update: Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a computerized chemosensory-based orbitofrontal cortex intervention targeting opioid use disorder; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• CBOT (Computerized Chemosensory-Based Orbitofrontal Cortex)

Snippet

Sponsor: Evon Medics LLC | Conditions: Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe | Phase 2 | Status: UNKNOWN